Xactly Corp

Chemical Management

Tata Chemicals Europe | June 24, 2022

Tata Chemicals Europe opened the UK's first industrial scale carbon capture and usage plant today, signalling a key milestone in the race to meet the UK's net zero targets. The £20 million investment has been completed by UK-based Tata Chemicals Europe, one of Europe's leading producers of sodium carbonate, salt and sodium bicarbonate. The plant captures 40,000 tonnes of carbon dioxide each year - the equivalent to taking over 20,000 cars off the roads and reduce...

ScienceDaily | April 06, 2020

Globally, there is increased interest and investment in sustainable forms of energy via commercialized renewable power technologies such as solar (thermal and photovoltaics), wind, biomass, geothermal, and other viable sources that are at the center stage. As part of the definitive pathways towards de-carbonization, investors, lenders, market players, and policymakers are increasingly becoming aware of the need for flexibility in the energy value and supply chain. This key area is a ...

Chemical Management

Peak Rock Capital | December 22, 2021

An affiliate of Peak Rock Capital ("Peak Rock"), a leading middle-market private investment firm, announced today that it has completed an acquisition of Xenon arc Inc. in partnership with the management team of the Company. Xenon arc is a leading technology-enabled provider of managed services to food & beverage, industrial, and chemical producer clients. The Company manages its clients' long tails of thousands of SMB customers collectively through its service o...

Okayama | October 07, 2020

In a recent study published in Scientific Reports researchers at Okayama University use stem cell models to show how certain chemical compounds can induce cancer. Stem cells have the unique ability to grow into any kind of cell within the body. A subtype of these, cancer stem cells (CSCs), reside within tumors enabling the aggressive growth of cancer. Researchers at Okayama University have previously converted ordinary stem cells into CSCs by growing them in tumor milieu. Now, for the first time...